Aromatase inhibitor use, side effects and discontinuation rates in gynecologic oncology patients

OBJECTIVE. Aromatase inhibitors (AI) are frequently prescribed in gynecologic oncology. We sought to define the frequency and duration of AI use, characterize AI side effects and determine the reasons for discontinuation in these patients. METHODS. Uterine and ovarian cancer patients with AI use for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gynecol Oncol
Main Authors: Bell, Sarah G., Dalton, Liam, McNeish, Brendan L., Fang, Fang, Henry, N. Lynn, Kidwell, Kelley M., McLean, Karen
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036903/
https://ncbi.nlm.nih.gov/pubmed/32847676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2020.08.015
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares